논문 목록
24건 · 최신순-
Update on Absorbable Facial Thread Lifts.
[BACKGROUND] Thread lifts are a noninvasive technique for suspending ptotic skin. Previous studies have failed to show long-term efficacy data with absorbable threads. [OBJECTIVE] To review the recent literature evaluating mid and lower fa…
- Hyperconcentrated glabellar injections to mitigate risk of botulinum toxin A-induced blepharoptosis: An unnecessary precaution.
-
Using Neuromodulators for Salivary, Eccrine, and Apocrine Gland Disorders.
[BACKGROUND] Sialorrhea, hyperhidrosis, bromhidrosis, and chromhidrosis are common glandular disorders that substantially impact patients' health and quality of life. Botulinum toxin can safely and temporarily decrease gland secretions by t…
-
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials.
DaxibotulinumtoxinA for Injection (DAXI) is a novel botulinum toxin type A product containing daxibotulinumtoxinA with a stabilizing excipient peptide (RTP004). DAXI immunogenicity was assessed in three phase 3 glabellar line studies (two p…
-
Bridging the Gap: Sustained Treatment Effect of Glabellar Lines With Twice-A-Year Treatment With DaxibotulinumtoxinA.
[BACKGROUND] To achieve natural-looking outcomes when treating dynamic lines with botulinum toxin (BoNT), retreatment must be timed such that the patient maintains a relatively constant aesthetic outcome. Although first-generation BoNT prod…
-
Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines.
DaxibotulinumtoxinA-lanm for injection (DAXI), a novel botulinum toxin type A formulation, contains a purified 150-kD core neurotoxin (daxibotulinumtoxinA) and proprietary stabilizing peptide (RTP004), and is approved for glabellar line tre…
-
Laser-Assisted and Device-Assisted Filler Delivery: A Histologic Evaluation.
[BACKGROUND] Lasers and devices are used to enhance transcutaneous delivery of fillers. However, little has been published on the histologic findings of this form of laser/device-assisted delivery to determine the optimal devices and filler…
-
Needle Manufacturing, Quality Control, and Optimization for Patient Comfort.
[INTRODUCTION] There is an increasing rise of cosmetic injectables. We sought to understand the manufacturing, quality control process, and needle selection of hypodermic needles for fillers. [OBJECTIVE] To understand the process of manufa…
-
The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
[BACKGROUND] PrabotulinumtoxinA is a 900-kDa botulinum toxin type A produced by Clostridium botulinum. [OBJECTIVES] The authors sought to investigate the safety of prabotulinumtoxinA for treatment of glabellar lines. [METHODS] This was a …
- Is Nonsurgical Rhinoplasty Portrayed as Risk-Free in Social Media ?
-
Delayed Inflammatory Reactions to Hyaluronic Acid Fillers: A Literature Review and Proposed Treatment Algorithm.
[BACKGROUND AND OBJECTIVES] There is a wide diversity of opinions regarding the management of delayed inflammatory reactions (DIRs) secondary to hyaluronic acid (HA)-based fillers. The plethora of approaches has led the authors to conduct a…
- A Path to Resume Aesthetic Care: Executive Summary of Project AesCert Guidance Supplement-Practical Considerations for Aesthetic Medicine Professionals Supporting Clinic Preparedness in Response to the SARS-CoV-2 Outbreak.
-
Botulinum Toxin in Aesthetic Medicine: Myths and Realities.
[BACKGROUND] Several formulations of Botulinum toxin serotype A (BoNT-A) for aesthetic indications are available, with numbers likely to increase. Preparations are not interchangeable, based on dose unit comparisons. [OBJECTIVE] Numerous m…
-
Safety and Effectiveness of the Hyaluronic Acid Filler, HYC-24L, for Lip and Perioral Augmentation.
[BACKGROUND] Hyaluronic acid gels are increasingly used for augmentation of the lips. [OBJECTIVE] To assess the safety and effectiveness of Juvéderm Ultra XC, a 24 mg/mL hyaluronic acid gel containing 0.3% (wt/wt) lidocaine (HYC-24L), for …
-
The filler revolution: a six-year retrospective.
There are currently more than 20 FDA-approved fillers in the United States (U.S.), noteworthy considering that it was only six years ago that the first hyaluronic acid filler was approved. The pace of development of filler substances in the…
-
Use of cutaneous lasers and light sources: appropriate training and delegation.
In recent years, there has been increasing concern among physicians, patient advocacy groups, and media watchdogs that laser, light, and cosmetic surgery are being practiced by poorly trained professionals, with resulting preventable injuri…
-
Effect of monopolar radiofrequency treatment over soft-tissue fillers in an animal model: part 2.
[BACKGROUND AND OBJECTIVE] Monopolar radiofrequency (RF) treatment is used by physicians to heat skin and promote tissue tightening and contouring. Cosmetic fillers are used to soften deep facial lines and wrinkles. Patients who have had de…
-
[Lasers and aesthetic dermatology].
The improved understanding of laser-tissue interaction along with the latest advances of laser technology have led to the development of sophisticated, safe, and user-friendly laser systems that provide effective treatment for a variety of …
- What is cosmetic surgery?
- On beauty: evolution, psychosocial considerations, and surgical enhancement.
- Aesthetic surgery: coming of age.
- Advances in cutaneous aesthetic surgery.
- Dermatology.
-
Laser skin resurfacing.
There has always been interest in looking younger, but recently there seems to have been an explosion of public interest in facial rejuvenation. Physicians have been treating photodamaged skin for many years by removing the epidermis and a …